“…In this context, photoallergy is associated with a cell-mediated immune response which is initiated by covalent binding of a light-activated hapten (for instance, a drug or a species derived therefrom) to a protein (Tokura, 2009; Ariza et al, 2011; Onoue et al, 2017). It is considered an emerging health concern due to the widespread use of topical drugs (including antibiotics, antifungals, antihistaminics, cardiovascular and nonsteroidal anti-inflammatory drugs), cosmetics, and nutraceutical in humans, which has attracted considerable attention from both industry and regulatory agencies (Schothorst et al, 1972; Girotti, 2001; Deleo, 2004; Dubakiene and Kupriene, 2006; Scheuer and Warshaw, 2006; Lugovic et al, 2007; Bylaite et al, 2009; Santoro and Lim, 2011; Elkeeb et al, 2012; Onoue et al, 2013; Honari, 2014; Kerstein et al, 2014; Scheinfeld et al, 2014; Onoue et al, 2016).…”